LOGIN  |  REGISTER
Chimerix
Assertio

AcariaHealth Sparks Innovation at 2025 Healthcare Advocate Summit with Hackathon and Expert Panels

August 26, 2025 | Last Trade: US$29.04 0.66 2.33

LAS VEGAS, Aug. 26, 2025 /PRNewswire/ -- AcariaHealth, a leader in specialty pharmacy solutions and a Centene Corporation company (NYSE: CNC), is taking center stage at the 2025 Healthcare Advocate Summit (Sept. 2–5) in Las Vegas with a first-of-its-kind "Reimagine Access" Hackathon and two can't-miss expert sessions.

Reimagine Access: A Hackathon for Healthcare Advocates

Tuesday, Sept. 2 | 1:00–3:30 PM PT | Florentine 1–11

This dynamic, hands-on session brings together healthcare advocates, providers, and pharmacy professionals for fast-paced, themed breakout discussions focused on real-world access challenges:

  • Breaking Bio – Biosimilars & Continuity of Care
  • No Place Like Home – Reimagining Home Infusion
  • Coverage Unlocked – Medicare/Medicaid Access
  • The Access Avengers – SP + Advocate Partnerships
  • Pharmaformers – Transforming Specialty Pharmacy

Guided by AcariaHealth Regional Sales Directors, each table invites participants to brainstorm actionable solutions they can take back to their organizations.

Expert Panel: Biosimilars & Market Disruption

Thursday, Sept. 4 | 1:30–2:20 PM PT

Join AcariaHealth leaders as they break down biosimilar trends, payer mandates, and how to prevent care disruption. Featuring a new video spotlighting our Provider Experience Managers (PEMs) and their impact on provider-pharmacy collaboration.

Panelists:

  • Alysha Robinson, PharmD, CSP – Director, Specialty Pharmacy Program Management
  • Kathleen Stenberg, PharmD, CSP – Lead Specialty Pharmacist, Operational Excellence
  • Robin Waida – Director, Physician Sales
  • Gil Rosas, BSN – Account Executive

Can't attend? Register for our October Biosimilars Webinar.

Roundtable: M3P Unpacked – Your Final Questions, Clarified

Friday, Sept. 5 | 8:30–9:30 AM PT | Pompeian 1–11
Speaker: Sheri Wallace - Account Executive

Wrap up the Summit with this interactive discussion on the Medicare Prescription Payment Plan (M3P) and its implications for patients and advocates. No slides—just your questions answered.

Advancing Access, Together

"At AcariaHealth, we believe access to care should be as seamless as the care itself," said Jessica Ciccolella-Kahl, CEO of AcariaHealth. "We're proud to lead these conversations and help drive lasting solutions."

From biosimilar transitions to breakthrough collaborations, AcariaHealth is committed to reshaping specialty pharmacy through innovation, advocacy, and compassion.

Heading to the Healthcare Advocate Summit? Stop by our sessions, meet the team, and follow us on LinkedIn for live updates.

About AcariaHealth

AcariaHealth is a national specialty pharmacy dedicated to supporting patients with complex conditions through personalized care and clinical expertise. As a Centene company, AcariaHealth leverages the strength of the largest Medicaid managed care organization to deliver transformative outcomes across the country.

Learn more: AcariaHealth.com
Follow us on LinkedIn

Viking Therapeutics

Stock Quote

Last Trade: US$29.04
Daily Change: 0.66 2.33
Daily Volume: 7,803,803
Market Cap: US$14.260B

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page